ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Sagiment Biosciences Inc

Sagiment Biosciences Inc (SGMT)

3.35
-0.07
(-2.05%)
Closed July 29 4:00PM
3.35
-0.04
(-1.18%)
After Hours: 6:56PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

SGMT News

Official News Only

SGMT Discussion

View Posts
Pip611 Pip611 4 weeks ago
Anyone know why this has been tanking so bad the last couple weeks?
👍️0
Monksdream Monksdream 3 months ago
SGMT under $5
👍️0
AGORDON AGORDON 5 months ago
Sagimet Biosciences (Nasdaq: SGMT $6.25)
Buy recommendation.

Market cap = $199M
Cash = $210M+ (Just raised $112M through a secondary offering)
Estimated cash burn = ($25)/year
Lead product = Denifanstat an oral, once daily pill and selective first-in-class FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).
Jan. 22, 2024 announced positive topline results from Phase 2b clinical trial of Denifanstat in Biopsy-confirmed F2/FS NASH.
The results are comparable to Madrigal's Resmitiron.
Ascletis collaboration agreement = Potential $122M in milestone payments as well as tiered royalties ranging from percentages in the high single digits to mid-teens on future net sales of Denifanstat, which is referred to as ASC40 in Greater China
Most AEs (adverse events) were Grade 1 or 2 (mild to moderate). There were no Grade 3 AEs.
👍️0
eneels01 eneels01 6 months ago
See if $10 level holds. MC could drift upward later this year towards $1B area as company is similar to ETNB…
👍️0
dinogreeves dinogreeves 6 months ago
Yup, got out at 16.25, thought they had enough in the coffers to push through this year. It was a good score while it lasted.
👍️0
TheFinalCD TheFinalCD 6 months ago
Sagimet Biosciences Announces Pricing of Public Offering of Series A Common Stock
https://newsfilter.io/articles/sagimet-biosciences-announces-pricing-of-public-offering-of-series-a-common-stock-c3511595df124183e48b41923f34e655

Sagimet Biosciences Announces Proposed Public Offering of Series A Common Stock
https://ir.sagimet.com/news-releases/news-release-details/sagimet-biosciences-announces-proposed-public-offering-series
👍️0
gail gail 6 months ago
congrats!
👍️0
dinogreeves dinogreeves 6 months ago
Only down 5% for after hours. Nothing to sweat over.
👍️0
dinogreeves dinogreeves 6 months ago
Three nice winners in my circle.
👍️0
dinogreeves dinogreeves 6 months ago
Looks like another run tomorrow.
👍️0
gail gail 6 months ago
that was fun! i love “bar charts as…



” i get a lot of good leads from that free website.
👍️0
gail gail 6 months ago
hey dino, looks like we got a runner here, weeeee!!
👍️0
gail gail 6 months ago
grabbed a few on the dip. hi all.
👍️0
dinogreeves dinogreeves 6 months ago
Looks like easy 500% gainer today.
👍️0
dinogreeves dinogreeves 6 months ago
What a great move and Baker Brothers in it, I simply got lucky at 11.38 with 2500 shares. Looks like billion dollar market cap is going to fetched here real soon.
👍️0
Awl416 Awl416 6 months ago
That 20k block they filled at 9.69 before ripping

Yummy
👍️0
Awl416 Awl416 6 months ago
Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH
👍️0